AAP
29
9
AAL
35
2
NWS
100
2
MCHP
71
8
WFC
83
6
MTB
75
6
CTSH
63
4
DUK
52
-3
VRTX
46
5
SIG
52
9
VRSK
73
-4
MAC
65
24
BXP
50
4
LEN
25
4
GD
55
-2
WBA
53
2
CMCSA
50
4
LMT
62
2
DHI
33
6
NWSA
91
-6
AAP
29
9
AAL
35
2
NWS
100
2
MCHP
71
8
WFC
83
6
MTB
75
6
CTSH
63
4
DUK
52
-3
VRTX
46
5
SIG
52
9
VRSK
73
-4
MAC
65
24
BXP
50
4
LEN
25
4
GD
55
-2
WBA
53
2
CMCSA
50
4
LMT
62
2
DHI
33
6
NWSA
91
-6
Financhill
Back

Organogenesis Holdings 10K Form

Sell
29

ORGO
Organogenesis Holdings

Last Price:
$3.19
Seasonality Move:
2.75%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-10 10Q ORGO/Organogenesis Holdings Quarterly
2020-05-11 10Q ORGO/Organogenesis Holdings Quarterly
2020-04-29 10K ORGO/Organogenesis Holdings Annual
2020-03-09 10K ORGO/Organogenesis Holdings Annual
2019-11-12 10Q ORGO/Organogenesis Holdings Quarterly
2019-08-09 10Q ORGO/Organogenesis Holdings Quarterly

Receive ORGO News And Ratings

See the #1 stock for the next 7 days that we like better than ORGO

ORGO Financial Statistics

Sales & Book Value

Annual Sales: $482M
Cash Flow: $-23.6M
Price / Cash Flow: 96.73
Annual Sales: $1.91
Price / Book: 1.56

Profitability

EPS (TTM): -0.17000
Net Income (TTM): $-15.9M
Gross Margin: $366.3M
Return on Equity: -5.05%
Return on Assets: -3.43%

Organogenesis Holdings Earnings Forecast

Key Organogenesis Holdings Financial Ratios

  • The Gross Profit Margin over the past 9 years for ORGO is 75.99%.
  • The Selling, General & Administrative Expenses for ORGO have been equal to 61.10% of Gross Profit Margin.
  • The Research & Development expenses have been 10.43% of Revenue.
  • The Interest Expense is 179.33% of Operating Income.
  • The Net Earning history of ORGO is 0.18% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 4 years.

Organogenesis Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ORGO
CUSIP: 68621F
Website: organogenesis.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.12
Quick Ratio: 3.28

Price-to-Earnings

Trailing P/E Ratio: 155.25
Forward P/E Ratio: 12.98

ORGO Technical Analysis vs Fundamental Analysis

Sell
29
Organogenesis Holdings (ORGO) is a Sell

Is Organogenesis Holdings a Buy or a Sell?